Canadian Public Policy Positions

For information about AstraZeneca's position on a number of key public policy issues that impact the innovative pharmaceutical industry, click the links below.

• Internet Pharmacy: Not in the best interest of Canadians
• The Common Drug Review: Faster access or more red tape?
• The Patent Act & Linkage Regulations: Essential tools for the advancement of medical science in Canada
• Therapeutic Substitution: Not what the doctor ordered
• Disease Management: Projects that improve health outcomes while delivering savings